Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,237-13,248 of 23,847
Drug study icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

Multiple locations, including San Diego
ADHDDrugA study involving a medication or substance.From 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Drug study icon
CompletedNCT00741598

Galantamine for Bipolarity

This study is completed in the United States. It is testing galantamine for Bipolarity.

Multiple locations, including Boston
BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Bipolarity
Drug study icon
SuspendedNCT06483789

HB-1 for Anxiety

This study is suspended in Australia. It is testing HB-1 for Anxiety.

Multiple locations, including Canberra
AnxietyDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
HB BioTech, LLC
Condition
Anxiety
Drug study icon
CompletedNCT00254202

Iloperidone Compared With Placebo and Active Control for schizophrenia

This study is completed in the United States and in India. It is testing iloperidone Compared With Placebo and Active Control for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, India
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Drug study icon
CompletedEUCTR 2014-000456-29

INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC for schizophrenia

This study is completed in Czechia, in Spain, and in Germany. It is testing INHALED LOXAPINE COMPARED WITH IM ANTIPSYCHOTIC for schizophrenia.

In Czech Republic
Bipolarity, SchizophreniaOther
Countries
Czechia, Spain, Germany
Sponsor
Ferrer Internacional, S.A.
Condition
Bipolarity, Schizophrenia
Behavioral study icon
CompletedNCT00735371

Lisdexamfetamine Dimesylate (LDX) for ADHD

This study is completed in the United States. It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.

Multiple locations, including Little Rock
ADHDBehavioralFrom 13 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

Multiple locations, including Brisbane
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
TerminatedNCT00771134

Lu AA39959 for depression in bipolarity

This study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.

In Atlanta
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
OngoingEUCTR 2019-002778-30

Memantine for Bipolarity

This study is ongoing in Italy. It is testing memantine for Bipolarity.

In Italy
BipolarityOther
Countries
Italy
Sponsor
IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA
Condition
Bipolarity
Drug study icon
CompletedNCT01239030

Methylphenidate HCl ER Capsules for ADHD

This study is completed in the United States. It is testing Methylphenidate HCl ER Capsules for ADHD.

Multiple locations, including Little Rock
ADHDDrugFrom 6 Years to 18 Years
Countries
United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.